PROLOR Biotech, Inc.
DelistedCIK 1268659fmd_0VEY9K6KX6YWK50Z2KAG5H2Z3KManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2006 to Jun 30, 2013, 17 periods
| Line item | FY2006 | FY2007 | FY2008 | FY2009 | FY2010 | FY2011 | FY2012 |
|---|---|---|---|---|---|---|---|
| Total revenues | – | – | – | – | 0 | 0 | 0 |
| Net interest income | – | – | – | (0) | 0 | (0) | – |
| Research and development | – | – | – | 6 | 5 | 12 | 15 |
| Operating income | – | – | – | (7) | (8) | (15) | (18) |
| Interest expense | – | – | – | – | 0 | 0 | 0 |
| Interest and investment income | – | – | – | – | 0 | 0 | 0 |
| Other non-operating income (expense) | – | – | – | – | 0 | (0) | 0 |
| Net income | (2) | (3) | (7) | (7) | (8) | (15) | (18) |